|
MRPL13 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.953800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.678600E-01 |
| Normal-vs-Stage2 |
5.716400E-01 |
| Normal-vs-Stage3 |
9.283600E-01 |
| Normal-vs-Stage4 |
9.136000E-01 |
| Stage1-vs-Stage2 |
3.479400E-01 |
| Stage1-vs-Stage3 |
6.645600E-01 |
| Stage1-vs-Stage4 |
9.031000E-01 |
| Stage2-vs-Stage3 |
6.548600E-01 |
| Stage2-vs-Stage4 |
6.486400E-01 |
| Stage3-vs-Stage4 |
8.832800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.589000E-01 |
| Normal-vs-AfricanAmerican |
4.334000E-01 |
| Normal-vs-Asian |
6.614600E-01 |
| Caucasian-vs-AfricanAmerican |
5.288000E-01 |
| Caucasian-vs-Asian |
6.435400E-01 |
| AfricanAmerican-vs-Asian |
5.739800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.264400E-01 |
| Normal-vs-Female |
5.002000E-01 |
| Male-vs-Female |
1.130950E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.664000E-01 |
| Normal-vs-Extreme_Weight |
9.436600E-01 |
| Normal-vs-Obese |
7.147400E-01 |
| Normal-vs-Extreme_Obese |
9.934000E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.837600E-01 |
| Normal_Weight-vs-Obese |
7.182000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.191000E-01 |
| Extreme_Weight-vs-Obese |
6.967000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.846600E-01 |
| Obese-vs-Extreme_Obese |
8.606800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.694800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.721800E-01 |
| Normal-vs-Age(61-80Yrs) |
7.967800E-01 |
| Normal-vs-Age(81-100Yrs) |
5.931000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.125400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.189000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.628600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.086400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.511600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.213200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.161400E-01 |
| Normal-VS-Type2 PRCC |
9.771200E-01 |
| Normal-VS-KIRP CIMP |
1.470570E-01 |
| Normal-VS-Unclassified PRCC |
1.777030E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.306800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.208000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.117600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.179200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.453800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.137210E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.107600E-01 |
| Normal-vs-N1 |
9.931800E-01 |
| Normal-vs-N2 |
8.846800E-01 |
| N0-vs-N1 |
8.028200E-01 |
| N0-vs-N2 |
7.488400E-01 |
| N1-vs-N2 |
8.142000E-01 |
|
|
